ispor 18th annual european congress congress 7-11 november 2015 mico ... slovak medical university...
Post on 07-Feb-2018
Embed Size (px)
ISPOR Congress App: see page 16
Wifi Network: Ispor
PROGRAM ANDSCHEDULE OF EVENTS
ISPOR 18th Annual European Congress
7-11 November 2015miCo milaNo CoNgressi
Impacting Health Decision Making with Outcomes Research: Closing the Gap
Tweet to @ISPORorg using #isPormilan
Membership by Geographic RegionISPOR Membership and ISPOR Regional Chapter Members
ISPOR Publications in EuropeValue in Health is the official journal of ISPOR. It provides a forum for researchers, health care decision makers, and policy makers to translate pharmacoeconomics and outcomes research into health care decisions.
> Access these publications at www.ispor.org >> Publications
8,700+ Regional Chapter Members 3,700+ Regional Chapter Members in Europe!
> If you are interested in joining ISPOR Regional Chapters in Europe, please contact: email@example.com.> If you are interested in joining the ISPOR Central and Eastern Europe Network, please contact firstname.lastname@example.org.
More than 9,500 Members Worldwide Including 3,600 members in Europe!
Regional Chapters and Networks in Europe
News Across Central & Eastern Europe, the ISPOR Central & Eastern Europe (CEE) Network newsletter, serves as a platform for the exchange of knowledge in the CEE region on current health care systems and policies, outcomes research, and education impacting health care research and policy decision making in CEE.
Value in Health Regional Issues publishes research and health policy articles specific to the Asia, Latin America, and Central & Eastern Europe, Western Asia and Africa (CEEWA) regions.
ISPOR Therapeutic and Diagnostic Device Outcomes Research book is available in Bosnian, Polish, Serbian, and Spanish.
ISPOR Book of Terms is available in multiple European languages.
2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Republic of Macedonia Chapter
Russia Far East Chapter
Russia HTA Chapter
Russia St. Petersburg Chapter
Turkish SCP Chapter
505 Lawrence Square Blvd South Lawrenceville, NJ 08648 Toll Free US and Canada: 1-800-992-0643 Tel: +1-609-586-4981 Fax: +1-609-586-4982 Email: email@example.com Internet: www.ispor.org
Translating Outcomes Research to Health Care Decisions
2015-2016 board of Directors
PresidentDaniel C. Malone, RPh, PhDProfessor of PharmacyUniversity of ArizonaTucson, AZ USA
President-electLou Garrison, PhDProfessor, Pharmaceutical Outcomes Research & Policy ProgramUniversity of Washington Seattle, Washington USA
Past PresidentAdrian Towse, MA, MPhilDirectorOffice of Health Economics London, UK
DirectorsJosephine Mauskopf, PhDVice President, Health EconomicsRTI Health Solutions Research Triangle Park, NC USA
Yen-Huei (Tony) Tarn, MS, PhDExecutive DirectorCenter for Pharmaceutical Care DevelopmentTaiwan Pharmacist AssociationTaipei, Taiwan
Dominik Tomek, PharmD, MPH, PhDInstitute of Clinical & Experimental PharmacologySlovak Medical UniversityBratislava, Slovakia
Karen Worley, PhDResearch ManagerComprehensive Health Insights (CHI)HumanaCincinnati, OH USA
Nancy Devlin, PhDDirectorOffice of Health EconomicsLondon, UK
Manuel Espinoza, MD, MSc, PhDProfessorPublic Health Institute of ChileMinistry of HealthSantiago, Chile
Dana Goldman, PhDProfessor of PharmacyUniversity of Southern California Los Angeles, CA USA
TreasurerZeba M. Khan, RPh, PhDVice President, Corporate ResponsibilityCelgene CorporationSummit, NJ USA
CEO & Executive DirectorNancy S. BergISPORLawrenceville, NJ USA
Daniel C. Malone, RPh, PhD 2015-2016 ISPOR President
As we celebrate ISPORs past accomplishments during our 20th Anniversary year, we are looking to a very bright future with our new strategic plan, updating Vision 2020.
Beginning with a planning session last winter, the Societys Board of Directors and other leaders have been involved in crafting new Vision and Mission Statements, along with updating the areas of strategic focus. The evolving plan focuses on ISPORs ongoing commitment to strengthen the integrity, advancement, and understanding of health economics and outcomes research globally.
I am proud to share with you the Mission and Vision Statements approved by the ISPOR Board of Directors. The new ISPOR Mission Statement is:
To promote health economics and outcomes research excellence to improve decision making for health globally.
In updating our new Vision and Mission Statement we emphasize the work that we do as researchers, payers, decision and policy makers, academicians, clinicians, and patients.
The previous Mission Statement, To increase the efficiency, effectiveness, and fairness of health care to improve health, did not focus specifically on health economic and outcomes research. We also wanted to reinforce our position as a global organization.
Our new Vision Statement:
ISPOR is the leading global scientific and educational organization for health economics and outcomes research and their use in decision making to improve health.
The previous Vision Statement, ISPOR is recognized globally as the authority for outcomes research and its use in health care decisions towards improved health, did not include the importance of ISPORs role as a leading educational organization.
Along with the Vision and Mission, the Board approved 5 Strategic Pillars that support our Vision and Mission.
SCIENTIFIC AND RESEARCH EXCELLENCE ISPOR is committed to strengthening the integrity, advancement and the understanding and use of health economics and outcomes research among researchers, health technology developers and assessors, regulators, health economists, health care policy makers, payers, providers, patients, populations, and society.
MEMBER ENGAGEMENT Through its worldwide membership and stakeholder groups, ISPOR has access to the ideas, knowledge, skills, and experiences that enable achievement of its mission. ISPOR offers membership benefits that are valued and essential in members professional growth.
EDUCATION AND TRAINING Knowledge and skill building are at the core of the ISPOR mission. ISPOR will lead efforts to strengthen and expand capabilities in health economics and outcomes research.
COMMUNICATION AND COLLABORATION ISPOR will be a valued and reliable resource for translating knowledge into practice for decision makers and stakeholders who include members, providers, payers, patients, professional societies, foundations, health authorities, the media, and others.
ORGANIZATIONAL VALUES ISPOR embraces a core set of values and standards that underlie all that we do.
Over the next months, the plan with accompanying goal statements will be shared with the membership.
A special thank you to CEO and Executive Director Nancy Berg and her staff for driving this planning process, that involved dozens of members in a condensed time frame.
I personally invite you to join us at the Member Meeting, Updating ISPOR Vision 2020,on Tuesday, November 10 at the 18th Annual European Congress in Milan, Italy where I will present the plan and engage members in discussing the future of our Society.
International Society for Pharmacoeconomics and Outcomes Research
Letter from the ISPOR President 3
Table of Contents 4
Letter from the ISPOR 18th Annual European Congress Program Committee Co-Chairs 5
Congress Committee Chairs 6
Congress at-a-Glance 7-8 Tear out entire page for quick reference!
ISPOR Invitational Group Meetings 9 Tear out entire page for quick reference!
Congress Room Floor Plan 10 Tear out entire page for quick reference!
Key Information 11
Event Sponsors 15
Congress App Information 16
Short Course Program 17
Program & Schedule of Events 25
Research Poster Presentations Overview 42
Research Poster Presentations Floor Plan 43
Issue Panel Descriptions 48
Workshop Descriptions 55
ISPOR Forum Descriptions 66
Sponsored Symposia 69
ISPOR 18th Annual European Congress Review Committee Members 75
Invited Speaker & Award Recipient Biographical Information 85
Exhibit Program 91
ISPOR Leadership Directory 141
7-11 November 2015 | MiCo Milano Congressi | Milan, ItalyISPOR 18th Annual European Congress
TABLE OF CONTENTS
With great pleasure we would like to welcome you to Milan for the ISPOR 18th Annual European Congress. The theme of the conference, Impacting Health Decision Making with Outcomes Research: Closing the Gap, will be centered on the use of outcomes assessment in decision making: Are we ready to use the developments and scientific endeavor of three decades of outcomes research for strategic policy making and day-to-day health services and technologies financing decisions?
In the opening plenary session on Monday, Strategy in Motion: The Current and Future Lifecycle Approach to Decision Making on Health Technologies, payers, health techno